Concepedia
Bioorganic & Medicinal Chemistry Letters · 2014 · 24 citations · 9 references
Open access
Medicinal ChemistryNatural SciencesDrug DiscoveryDiversity-oriented Synthesis-One AnalogsMedicineOrganic ChemistryHeterocycle ChemistryPharmacologyPharmaceutical ChemistrySynthetic ChemistryBiomolecular Engineering
9
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
Nora Göckler, Guillermo Jofré, Chrisovalantis Papadopoulos et al. · FEBS Journal · 2009 · 269 citations · Full text
Down Syndrome, Tyrosine Autophosphorylation, Protein Kinase Dyrk1a +12
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Yasushi Ogawa, Yosuke Nonaka, Toshiyasu Goto et al. · Nature Communications · 2010 · 264 citations · Full text
Signal Transduction, Medicine, Receptor Tyrosine Kinase +4
β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
Danielle Frost, Bessie Meechoovet, Tong Wang et al. · PLoS ONE · 2011 · 161 citations · Full text
Synaptic Signaling, Tau Protein, Serine 396 +21
DNA binding properties of 9-substituted harmine derivatives
Rihui Cao, Wenlie Peng, Hongsheng Chen et al. · Biochemical and Biophysical Research Communications · 2005 · 158 citations
Natural Sciences, 9-Substituted Harmine Derivatives, Molecular Biology +4
Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
M. Soundararajan, A.K. Roos, P. Savitsky et al. · Structure · 2013 · 154 citations · Full text